Zimmer Biomet Holdings Inc.'s Proposed Bonds Rated 'BBB' - S&P Global Ratings’ Credit Research

Zimmer Biomet Holdings Inc.'s Proposed Bonds Rated 'BBB'

Zimmer Biomet Holdings Inc.'s Proposed Bonds Rated 'BBB' - S&P Global Ratings’ Credit Research
Zimmer Biomet Holdings Inc.'s Proposed Bonds Rated 'BBB'
Published Aug 27, 2025
3 pages (1270 words) — Published Aug 27, 2025
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

BOSTON (S&P Global Ratings) Aug. 27, 2025--S&P Global Ratings today assigned its 'BBB' issue rating to Zimmer Biomet Holdings Inc. ?s proposed Swiss franc-denominated senior unsecured bonds, issued in two tranches (amounts and maturities to be determined). The company will use the net proceeds from these bonds for its general corporate purposes, which may include repayment of debt, share repurchases, financing capital commitments and future acquisitions, among other things. Our ?BBB? issuer credit rating and stable outlook on Zimmer Biomet are unchanged. Consistent with our previous forecast, we expect the recent acquisitions of Paragon 28 and Monogram Technologies Inc. will increase leverage to about 3.0x-3.3x in 2025 from about 2.6x in 2024, given the negligible initial EBITDA contribution from these

  
Brief Excerpt:

...August 27, 2025 BOSTON (S&P Global Ratings) Aug. 27, 2025--S&P Global Ratings today assigned its '###' issue rating to Zimmer Biomet Holdings Inc.'s proposed Swiss franc-denominated senior unsecured bonds, issued in two tranches (amounts and maturities to be determined). The company will use the net proceeds from these bonds for its general corporate purposes, which may include repayment of debt, share repurchases, financing capital commitments and future acquisitions, among other things. Our `###' issuer credit rating and stable outlook on Zimmer Biomet are unchanged. Consistent with our previous forecast, we expect the recent acquisitions of Paragon 28 and Monogram Technologies Inc. will increase leverage to about 3.0x-3.3x in 2025 from about 2.6x in 2024, given the negligible initial EBITDA contribution from these acquisitions, upfront integration and development costs, and sizable contingent considerations related to the Monogram acquisition (Monogram common stockholders will receive...

  
Report Type:

Ratings Action

Ticker
ZBH
Issuer
Zimmer Biomet Holdings Inc.
GICS
Health Care Equipment (35101010)
Sector
Global Issuers
Country
United States
Region
United States
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Zimmer Biomet Holdings Inc.'s Proposed Bonds Rated 'BBB'" Aug 27, 2025. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/Zimmer-Biomet-Holdings-Inc-s-Proposed-Bonds-Rated-BBB-3430935>
  
APA:
S&P Global Ratings’ Credit Research. (). Zimmer Biomet Holdings Inc.'s Proposed Bonds Rated 'BBB' Aug 27, 2025. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/Zimmer-Biomet-Holdings-Inc-s-Proposed-Bonds-Rated-BBB-3430935>
  
US$ 150.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.